# Quanome Technologies, Inc.: overview QNME · Nasdaq · CIK 1996192 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/qnme.md) · [Financials](/companies/qnme/financials.md) · [Filings](/companies/qnme/filings.md) · [Insiders](/companies/qnme/insiders.md) Latest reported revenue: [$742.3k](/filings/0001213900-26-103571.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Sep 25, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-103571). ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [4,082](/filings/0001213900-24-098389.md) | [3,596](/filings/0001213900-26-018466.md) | [497](/filings/0001213900-26-059117.md) | [2,047 d](/filings/0001213900-26-103571.md) | [6,100](/filings/0001213900-25-112601.md) | [7,013](/filings/0001213900-26-018466.md) | [1,328](/filings/0001213900-26-059117.md) | [742 d](/filings/0001213900-26-103571.md) | | Gross margin | % | [12.8%](/filings/0001213900-25-112601.md) | [(1.2%)](/filings/0001213900-26-018466.md) | [76.0%](/filings/0001213900-26-059117.md) | [52.5% d](/filings/0001213900-26-103571.md) | [18.2%](/filings/0001213900-25-112601.md) | [27.2%](/filings/0001213900-26-018466.md) | [73.8%](/filings/0001213900-26-059117.md) | [72.8% d](/filings/0001213900-26-103571.md) | | Operating margin | % | [(32.5%)](/filings/0001213900-25-112601.md) | [(55.6%)](/filings/0001213900-26-018466.md) | [(66.3%)](/filings/0001213900-26-059117.md) | [(0.2%) d](/filings/0001213900-26-103571.md) | [(20.8%)](/filings/0001213900-25-112601.md) | [(21.3%)](/filings/0001213900-26-018466.md) | [(118.7%)](/filings/0001213900-26-059117.md) | [(915.5%) d](/filings/0001213900-26-103571.md) | | Net margin | % | [(32.7%)](/filings/0001213900-25-112601.md) | [(54.1%)](/filings/0001213900-26-018466.md) | [(215.3%)](/filings/0001213900-26-059117.md) | [(43.6%) d](/filings/0001213900-26-103571.md) | [(22.2%)](/filings/0001213900-25-112601.md) | [(22.6%)](/filings/0001213900-26-018466.md) | [10.7%](/filings/0001213900-26-059117.md) | [(900.7%) d](/filings/0001213900-26-103571.md) | | Diluted EPS | $ per share | [(0.18)](/filings/0001213900-25-112601.md) | [(0.26)](/filings/0001213900-26-018466.md) | [(0.14)](/filings/0001213900-26-059117.md) | not reported | [(0.09)](/filings/0001213900-25-112601.md) | [(0.08)](/filings/0001213900-26-018466.md) | [0.01](/filings/0001213900-26-059117.md) | not reported | | Free cash flow | $k | [(1,409)](/filings/0001213900-25-112601.md) | [(561) d](/filings/0001213900-26-018466.md) | [(263) d](/filings/0001213900-25-044205.md) | [(493) d](/filings/0001213900-25-098720.md) | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [12.9](/filings/0001213900-24-083350.md) | [18.3](/filings/0001213900-24-083350.md) | [2.8](/filings/0001213900-26-103571.md) | [5.9](/filings/0001213900-26-103571.md) | | Gross margin | % | [19.9%](/filings/0001213900-24-083350.md) | [20.3%](/filings/0001213900-25-098720.md) | [56.1%](/filings/0001213900-26-103571.md) | [56.7%](/filings/0001213900-26-103571.md) | | Operating margin | % | [1.9%](/filings/0001213900-24-083350.md) | [(2.9%)](/filings/0001213900-25-098720.md) | [(54.0%)](/filings/0001213900-26-103571.md) | [(174.2%)](/filings/0001213900-26-103571.md) | | Net margin | % | [7.6%](/filings/0001213900-24-083350.md) | [(1.2%)](/filings/0001213900-25-098720.md) | [(189.9%)](/filings/0001213900-26-103571.md) | [(162.1%)](/filings/0001213900-26-103571.md) | | Diluted EPS | $ per share | [0.16](/filings/0001213900-24-083350.md) | [(0.04)](/filings/0001213900-25-098720.md) | [(0.69)](/filings/0001213900-26-103571.md) | [(0.36)](/filings/0001213900-26-103571.md) | | Free cash flow | $m | [0.0](/filings/0001213900-24-083350.md) | not reported | [(2.7)](/filings/0001213900-25-098720.md) | [(3.2)](/filings/0001213900-26-103571.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/qnme/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $128.3k | 295,675 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $74.0k | 170,411 | | Reduced −1,740 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $58.6k | 135,121 | | Unchanged | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $14.2k | 32,690 | | Unchanged | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $1.3k | 3,005 | | Added +1,920 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $1.3k | 2,939 | | New +2,939 | | [Virtu Financial LLC](/funds/1533964.md) | 2026-06-30 | $5 | 10,410 | | New +10,410 | ## Recent filings [All 122 filings](/companies/qnme/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-21 | 16:25 ET | [8-K](/filings/0001213900-26-111358.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-111358 | | 2026-10-09 | 10:58 ET | [8-K](/filings/0001213900-26-108295.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-108295 | | 2026-10-05 | 06:31 ET | [8-K](/filings/0001213900-26-106621.md) | 1.01 Entry into a material agreement | 0001213900-26-106621 | | 2026-10-01 | 16:09 ET | [8-K](/filings/0001213900-26-105778.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-105778 | | 2026-09-25 | 16:46 ET | [10-K](/filings/0001213900-26-103571.md) | Annual report, period 2026-06-30 | 0001213900-26-103571 | | 2026-09-25 | 20:00 ET | [8-K/A](/filings/0001213900-26-103163.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-103163 | | 2026-09-23 | 10:11 ET | [8-K](/filings/0001213900-26-102450.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-102450 | | 2026-09-21 | 16:45 ET | [8-K](/filings/0001213900-26-101830.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-101830 | | 2026-09-21 | 16:15 ET | [8-K](/filings/0001213900-26-101812.md) | 1.01 Entry into a material agreement | 0001213900-26-101812 | | 2026-08-20 | 12:30 ET | [8-K](/filings/0001213900-26-091979.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-091979 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001213900-26-103571.md), filed Sep 25, 2026. ## Forecast league Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/908deec4-6154-4a6c-aea9-018f80964823) ## About the filer - CIK: 1996192 - Tickers: QNME - Exchange: Nasdaq - SIC code: 4731 Arrangement of Transportation of Freight & Cargo - State of incorporation: NV - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 08:16 ET. No prices; not investment advice.